







































































































chieved important reductions in the incidence of Chagas
isease in many Latin American countries. However, this
pproach has been ineffective in some geographic areas
uch as the Gran Chaco. As a result, the development of
ffective new tools in these areas to prevent house rein-
estation by triatomine bugs is a high research priority. No
ess important is the need of innovative approaches includ-
ng those generated from genomics to improve upon existing
iagnostic tests and to develop new parasitological tests
or the early diagnosis of congenital infection in the new-
orn and in immunocompromised patients, as well as for
he assessment of treatment response (PCR; antigenemia,
ecombinant antigens,synthetic peptides etc.). There is also
pressing need of developing new anti-T. cruzi agents with
igh activity in both the acute and chronic phases, and epi-
emiological methods that me may be used to estimate the
revalence of infection, subclinical disease and treatment
eeds in endemic and non-endemic countries.
oi:10.1016/j.ijid.2010.02.1871
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ntegrated control of neglected tropical diseases in Africa
.J. Bockarie
Centre for Neglected Tropical Diseases, Liverpool, United
ingdom
Neglected tropical diseases (NTD) are the ‘other dis-
ases’ of Millennium Development Goal 6 that have received
ittle attention from policy-makers and politicians who
ver focus on HIV, tuberculosis and malaria. They include
any medically diverse diseases that are strongly associ-
ted with poverty. NTDs include bacterial, viral, protozoan
nd helminth infections that have plagued humanity since
ntiquity. Globally, over one billion people suffer from one
r more NTDs and about 500,000 people die from them every
ear.
Neglected Tropical Diseases are widespread in Africa due,
n part, to the low socio-economic status of rural popula-
ions. Many countries are endemic with of 5 or more NTDs
ncluding schistosomiasis, soil-transmitted helminths (STH),
ymphatic ﬁlariasis, onchocerciasis and trachoma, as well
s zoonotic disease such as human African trypanosomiasis,
abies, tick borne relapsing fevers, echinococcus (hydatid),
aeniosis (cysticercosis), brucellosis and plague, with a large
art of the population at risk of co-infection with 2 or more
f these diseases.
Fortunately, control strategies as well as diagnostic tools
nd the availability of safe and effective drugs exist for the
TDs responsible for the greatest burden in Africa: lym-
hatic ﬁlariasis, onchocerciasis, STH and schistosomiasis.
he World Health Organization has developed a strategy,
reventive Chemotherapy and Transmission Control (PCT),
hich is geared towards the implementation of large-scale
ass drug administration. The objective of PCT is to pro-
ide national programmes with technical guidelines that
mphasize a coordinated, cost-effective approach to the
mplementation of national elimination and control activ-
ties where preventive chemotherapy is the main tool, i.e.
egular anthelminthic drug administration to all people at





iternational Congress on Infectious Diseases (ICID) Abstracts
n life. The availability of rapid diagnostic tools and dona-
ions of several drugs from pharmaceutical companies, and
he reduced price of other essential antihelminthic drugs
as catalysed the rapid expansion of chemotherapy-based
ontrol programmes for NTDs. The main challenges to PTC
n Africa include poor health service infrastructure in post
onﬂict countries and cost-effective approaches for inte-
rating the individual vertical programmes targeting speciﬁc
iseases.
oi:10.1016/j.ijid.2010.02.1872
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nusual clinical proﬁle of Dengue Infection in patients
ttending a tertiary care teaching hospital in north India
. Agarwal ∗, G. Kapoor, S. Srivastava, K.P. Singh, R. Kumar,
. Jain
C S M Medical University, Lucknow, Uttar pradesh, India
Background: Major outbreaks of dengue virus have been
eported from many parts of North India including Luc-
now, at regular intervals since 1996. We have carried out a
etailed investigation of the Dengue cases occurring in year
008.
Methods: Clinically suspected patients attending Pedi-
trics and Medicine outpatient or inpatient Departments and
eferred to Microbiology Department for serological diagno-
is of dengue, were prospectively enrolled after obtaining
erbal consent. Detailed clinical history and examination
ndings were recorded in a pre designed questionnaire from
98 such patients between Jan 2008 to Dec 2008. Dengue
peciﬁc antibodies were detected using commercial Mac-
LISA kit (IVD, USA). Results of hematological and other
nvestigations were noted from medical records.
Results: Mean age of patients’ was10.25± 10.9 years and
28/398 were in pediatric age group (%12 yrs age). A total of
3.26% (212/398) patients were positive for dengue IgM and
3% of these were admitted patients. Male: Female ratio
as1.8:1 and ∼74% belonged to rural area. Overwhelming
ajority (92%) of dengue cases were seen between July
o November, which are the post monsoon months in this
art of world. Frequent clinical features included fever
100%) withmean duration of 14.07± 9.2 days, edema (50%),
ltered sensorium (39%), rash (31.84%). Mucosal bleeding,
epatomegaly and splenomegaly were present in 31.84%,
7.29% and 56.25% respectively. Thrombocytopenia (58.74%)
as common laboratory ﬁnding. Liver enzymes SGPT and
GOT were raised in 72.55% and 78.43% of positive cases,
espectively. Presentation varied between adults and pedi-
tric populations, while among adults, seizure (p = 0.029),
kin rash (p = 0.029), abdominal pain (p = 0.005) and hemo-
oncentration (PCV > 36; p = 0.063) were signiﬁcant ﬁndings;
owever in children, headache (p = 0.029), serum sodium
nd calcium levels (p = 0.022 and p = .0006) were signif-
cantly raised. Logistic Regression analysis found serum
GOT>40 U/L and presence of splenomegaly as independent
redictors for dengue infection. Only 3 cases met the WHO
riteria for dengue haemorrhagic fever (DHF), however clin-
cally ∼20% of the dengue positive cases were labelled and
